Peptide Therapy: Separating Science from Hype

This video examines the growing trend of peptide therapy, distinguishing between FDA-approved medical treatments and unregulated wellness supplements. A biomedical scientist analyzes online discussions to clarify what peptides are, their actual efficacy, and the significant safety risks associated with gray market products.

■ Understanding Peptides and Medical Standards
- Definition of peptides as amino acid chains versus marketing claims
- Examples of approved peptides like insulin and semaglutide
- Distinction between therapeutic use and experimental compounds

■ Popular Peptide Stacks and Claims
- Analysis of the "Wolverine Stack" (BPC-157 and TB-500) for injury recovery
- Examination of libido-enhancing peptides like PT-141 and Melanotan II
- Review of topical peptides for anti-aging and skin health

■ Safety Risks and Regulatory Issues
- Lack of human clinical data for many popular peptides
- Contamination risks including heavy metals and impurities in unregulated vials
- Dangers of self-injection and non-sterile preparation methods
- Explanation of the "Research Use Only" label and gray market sales

■ Conclusion on Peptide Legitimacy
- Identification of which peptides have robust evidence versus those lacking safety data
- Guidance for viewers on evaluating sources and understanding regulatory oversight
- Final assessment on the balance between potential benefits and serious health risks